Wess J[au] - Search Results

Year	Number of Results
1978	1
1979	1
1981	2
1982	2
1984	2
1986	1
1987	4
1988	2
1989	4
1990	4
1991	3
1992	6
1993	6
1994	5
1995	7
1996	10
1997	7
1998	7
1999	9
2000	4
2001	12
2002	13
2003	14
2004	13
2005	19
2006	12
2007	14
2008	14
2009	18
2010	20
2011	18
2012	16
2013	13
2014	12
2015	8
2016	10
2017	10
2018	8
2019	14
2020	9
2021	11
2022	4

1

Key Metabolic Functions of β-Arrestins: Studies with Novel Mouse Models.

Pydi SP, Barella LF, Meister J, Wess J. Pydi SP, et al. Among authors: wess j. Trends Endocrinol Metab. 2021 Feb;32(2):118-129. doi: 10.1016/j.tem.2020.11.008. Epub 2020 Dec 23. Trends Endocrinol Metab. 2021. PMID: 33358450 Review.

2

Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications.

Meister J, Wang L, Pydi SP, Wess J. Meister J, et al. Among authors: wess j. J Neurochem. 2021 Aug;158(3):603-620. doi: 10.1111/jnc.15314. Epub 2021 Mar 10. J Neurochem. 2021. PMID: 33540469 Review.

3

Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs.

Wang L, Zhu L, Meister J, Bone DBJ, Pydi SP, Rossi M, Wess J. Wang L, et al. Among authors: wess j. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:421-440. doi: 10.1146/annurev-pharmtox-030220-121042. Epub 2020 Aug 3. Annu Rev Pharmacol Toxicol. 2021. PMID: 32746768 Review.

4

The Two β-Arrestins Regulate Distinct Metabolic Processes: Studies with Novel Mutant Mouse Models.

Wess J. Wess J. Int J Mol Sci. 2022 Jan 2;23(1):495. doi: 10.3390/ijms23010495. Int J Mol Sci. 2022. PMID: 35008921 Free PMC article. Review.

5

Beta-cell M₃ muscarinic acetylcholine receptors as potential targets for novel antidiabetic drugs.

Zhu L, Rossi M, Doliba NM, Wess J. Zhu L, et al. Among authors: wess j. Int Immunopharmacol. 2020 Apr;81:106267. doi: 10.1016/j.intimp.2020.106267. Epub 2020 Feb 7. Int Immunopharmacol. 2020. PMID: 32044662 Review.

6

Novel muscarinic receptor mutant mouse models.

Wess J. Wess J. Handb Exp Pharmacol. 2012;(208):95-117. doi: 10.1007/978-3-642-23274-9_6. Handb Exp Pharmacol. 2012. PMID: 22222697 Review.

7

Engineering GPCR signaling pathways with RASSLs.

Conklin BR, Hsiao EC, Claeysen S, Dumuis A, Srinivasan S, Forsayeth JR, Guettier JM, Chang WC, Pei Y, McCarthy KD, Nissenson RA, Wess J, Bockaert J, Roth BL. Conklin BR, et al. Among authors: wess j. Nat Methods. 2008 Aug;5(8):673-8. doi: 10.1038/nmeth.1232. Nat Methods. 2008. PMID: 18668035 Free PMC article. Review.

8

Conformational changes involved in G-protein-coupled-receptor activation.

Wess J, Han SJ, Kim SK, Jacobson KA, Li JH. Wess J, et al. Trends Pharmacol Sci. 2008 Dec;29(12):616-25. doi: 10.1016/j.tips.2008.08.006. Epub 2008 Oct 4. Trends Pharmacol Sci. 2008. PMID: 18838178 Free PMC article. Review.

9

In Vivo Metabolic Roles of G Proteins of the Gi Family Studied With Novel Mouse Models.

Wess J. Wess J. Endocrinology. 2022 Jan 1;163(1):bqab245. doi: 10.1210/endocr/bqab245. Endocrinology. 2022. PMID: 34871353 Review.

10

Muscarinic acetylcholine receptors: novel opportunities for drug development.

Kruse AC, Kobilka BK, Gautam D, Sexton PM, Christopoulos A, Wess J. Kruse AC, et al. Among authors: wess j. Nat Rev Drug Discov. 2014 Jul;13(7):549-60. doi: 10.1038/nrd4295. Epub 2014 Jun 6. Nat Rev Drug Discov. 2014. PMID: 24903776 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results